EcoDrugPlus

Ensembl ID : YKL216W
Description: -
125 Possible Orthologues:

Title

Ensembl ID : YLL045C
Description: -
104 Possible Orthologues:

Title

Ensembl ID : YLR029C
Description: -
116 Possible Orthologues:

Title

Ensembl ID : YLR048W
Description: -
131 Possible Orthologues:

Title

Ensembl ID : YLR070C
Description: -
155 Possible Orthologues:

Title

Ensembl ID : YLR075W
Description: -
123 Possible Orthologues:

Title

Ensembl ID : YLR174W
Description: -
134 Possible Orthologues:

Title

Ensembl ID : YLR188W
Description: -
1259 Possible Orthologues:

Title

Ensembl ID : YLR209C
Description: -
126 Possible Orthologues:

Title

Ensembl ID : YLR210W
Description: -
265 Possible Orthologues:

Title

Ensembl ID : YLR260W
Description: -
77 Possible Orthologues:

Title

Ensembl ID : YLR264W
Description: -
57 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).